Dube Eric M 的 Form 4 申報
Travere Therapeutics, Inc.TVTX,2026/10/19 申報
- 申報編號
- 0001763494-26-000008
- 申報時間
- 2026/10/19 16:05 ET
- 交易日
- 2026/10/15
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 5 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $1,312 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Dube Eric MCIK 0001763494 | 董事、高階主管(執行長) |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/10/15 | Common Stock | M行使選擇權取得 | +43,735 | $26.88 | +$1,175,596.8 | 476,621 | 直接 | |
| 2026/10/15 | Common Stock | M行使選擇權取得 | +200,000 | $8.93 | +$1,786,000 | 676,621 | 直接 | |
| 2026/10/15 | Common Stock | S賣出處分 | −128,065 | $52.97F2 | −$6,783,244.47 | 548,556 | 直接 | |
| 2026/10/15 | Common Stock | S賣出處分 | −37,270 | $54.20F3 | −$2,020,022.82 | 511,286 | 直接 | |
| 2026/10/15 | Common Stock | S賣出處分 | −78,400 | $55.02F4 | −$4,313,403.36 | 432,886 | 直接 |
衍生性證券(表 II)
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/10/15 | Common Stock | M行使選擇權處分 | −43,735 | $0.00 | $0 | 168,925 | 直接 | |
| 2026/10/15 | Common Stock | M行使選擇權處分 | −200,000 | $0.00 | $0 | 160,000 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F2
The weighted average sale price for the transaction reported was $52.9672, and the range of prices were between $52.63 and $53.6250. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The weighted average sale price for the transaction reported was $54.1997, and the range of prices were between $53.63 and $54.62. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The weighted average sale price for the transaction reported was $55.0179, and the range of prices were between $54.63 and $55.57. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。